SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo US Bio Tech informs about outcome of board meeting

16 Jun 2026 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Master Circulars issued thereunder, Indo US Bio Tech has informed that the Board of Directors of the Company at its meeting held on 16th June 2026, has considered and approved the following: 1. Noted the Resignation of Gautam N Associates, Chartered Accountants (FRN: 103117W), from the office of Statutory Auditor of the Company with effect from 15 June 2026. 2. Approved the Appointment of Bhagat & Associates, Chartered Accountants (FRN: 101100W), as Statutory Auditor of the Company with effect from 16th June 2026, subject to approval of the shareholders. 3. Noted the Resignation of Raj Shah & Co. (CA. Raj Shah) Proprietor (FRN: 141020W), (Membership Number: 166492) as Internal Auditor of the Company with effect from 15th June 2026. 4. Approved the appointment of J. M. Raval & Co. (CA J. M. RAVAL) Proprietor, (FRN: 123560W), Membership No.: 113830 as Internal Auditor of the Company with effect from 16t June 2026. The details as required under Regulation 30 of the SEBI (LODR) Regulations, 2015 read with SEBI Circular No. SEBVHO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed as Annexure A. The Board Meeting commenced at 15:00 pm and concluded at 15:30 pm.

The above information is a part of company’s filings submitted to BSE. 

Indo US Bio-Tech Share Price

90.25 1.45 (1.63%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1423.35
Mangalam Global Ent 15.75
Kaveri Seed 848.90
Regaal Resources 77.51
Simran Farms 164.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: